Daniel Muheme

A selection of Mr. Muheme’s experience includes representing:

• GRAIL in the European Commission’s Phase II investigation in its acquisition by Illumina and related EU litigation
• A technology company in a Phase II investigation before the CMA*
• Merck with worldwide merger control filings for its acquisition of Antelliq*
• A manufacturer in a cartel investigation before the European Commission in the styrene monomer cartel*
• A technology company in Articles 101 and 102 TFEU investigations before the European Commission and the KFTC*
• A pharmaceutical company in an investigation by the CMA under Chapters I and II of the Competition Act and Articles 101 and 102 TFEU in relation to alleged excessive pricing practices*
• Elbit Systems in its US$380 million acquisition of Sparton Corporation*
• DPG Media on the sale of its Belgian mobile telecom subsidiary Mobile Vikings to Proximus Group*
• A number of companies in relation to compliance investigations and trainings*

*Matter handled prior to joining the firm

Thought Leadership

• “National Report on Discriminatory Practices in Belgian Competition Law” in Competition Law Analysis of Price and Non-price Discrimination & Abusive IP Based Legal Proceedings (2021)
• “Due Process in Antitrust Proceedings and the Quest for Global Convergence” in An Antitrust Professor on the Bench – Liber Amicorum, Douglas H. Ginsburg, Vol. II, Concurrences (2020) 
• “Procedural Rights in EU Antitrust Proceedings” (pp. 129-160), in Procedural Rights in Competition Law in the EU and China (C. Cauffman and Q. Hao), Springer  (2016)